deltatrials
Terminated PHASE4 INTERVENTIONAL NCT00148252

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant - Randomised Withdrawal of Mycophenolate Mofetil (CellCept®) or Cyclosporine A (Sandimmun Neoral®)

Sponsor: University of Oslo School of Pharmacy

Conditions Renal Transplantation
Interventions Cyclosporione A withdrawal Mycophenolate mofetil withdrawal
Updated 5 times since 2017 Last updated: Jun 6, 2012 Started: Feb 28, 2003 Primary completion: Nov 30, 2005 Completion: Feb 28, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

To high rejection rate in CsA withdrawal arm

Other terminated trials from University of Oslo School of Pharmacy

See all terminations from University of Oslo School of Pharmacy

Other Renal Transplantation trials with similar outcome

Browse all Renal Transplantation trials

A PHASE4 clinical study on Renal Transplantation, this trial is terminated or withdrawn. The trial is conducted by University of Oslo School of Pharmacy and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    First recorded

Feb 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Oslo School of Pharmacy
Data source: University of Oslo School of Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations